CTLA4 and neoplasm: Tumor cells and some immunosuppressive cells (including some bone marrow-derived suppressor cells, such as M2 macrophages) can highly express immunosuppressive signaling proteins (such as PD-L1 and CTLA-4) and bind to receptors on activated antitumor immune cells to achieve immunosuppressive effects [90].